You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 2, February 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Plasminogen in the Prevention of Hyaline Membrane Disease

Clara M. Ambrus, MD, PhD; David H. Weintraub, MD; Thai S. Choi, MD; Bernard Eisenberg, MD; Henry P. Staub, MD; Norman G. Courey, MD; Ronald J. Foote, MD; Dean Goplerud, MD; Robert V. Moesch, MD; Michael Ray, MD; Irwin D. J. Bross, PhD; Okhee S. Jung, MS; Irving B. Mink, MS; Julian L. Ambrus, MD, PhD

Am J Dis Child. 1974;127(2):189-194.


Abstract

Alveolar hyaline membranes in hyaline membrane disease (HMD) consist partly of fibrin. Premature infants lack serum plasminogen, thus they are unable to develop effective fibrinolysis and are defenseless against fibrin deposition. Therefore, plasminogen was tested for the prevention of HMD.

In a double-blind randomized study, 100 infants between 1.0 and 2.5 kg birthweight received plasminogen or placebo soon after birth. Factors placing the infant at risk from HMD were found to be evenly divided between control and treated groups.

Among the 51 infants who received placebo, seven developed mild, and ten developed severe respiratory distress; of these ten, five died with HMD. Two infants died from causes other than HMD.

Among the 49 infants treated with plasminogen, 13 developed mild and three developed severe respiratory distress. There was no death due to HMD. Two deaths were due to other causes.



Author Affiliations

Buffalo

From the departments of pediatrics (Drs. C. Ambrus, Weintraub, Choi, Eisenberg, and Staub), obstetrics and gynecology (Drs. Courey, Foote, Goplerud, Moesch, and Ray), and internal medicine (Dr. J. Ambrus), State University of New York at Buffalo; and the Roswell Park Memorial Institute (Drs. Ambrus, Bross, and Ambrus, and Messrs. Jung and Mink), Buffalo.


Footnotes

Received for publication May 21, 1973; accepted Sept 9.

Reprint requests to Roswell Park Memorial Institute, 666 Elm St, Buffalo 14203 (Dr. C. Ambrus).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nutrition and Infectious Diseases in Developing Countries and Problems of Acquired Immunodeficiency Syndrome
Ambrus and Ambrus
Exp. Biol. Med. 2004;229:464-472.
ABSTRACT | FULL TEXT  

Prevention of Hyaline Membrane Disease With Plasminogen: A Cooperative Study
Ambrus et al.
JAMA 1977;237:1837-1841.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.